Nicholas Grund Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Nicholas Grund is Chief Commercial Officer of Akebia Therapeutics, Inc.. Currently has a direct ownership of 442,579 shares of AKBA, which is worth approximately $947,119. The most recent transaction as insider was on Feb 03, 2025, when has been sold 55,621 shares (Common Stock) at a price of $2.1 per share, resulting in proceeds of $116,804. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 443K
45.92% 3M change
45.92% 12M change
Total Value Held $947,119

Nicholas Grund Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 03 2025
SELL
Open market or private sale
$116,804 $2.1 p/Share
55,621 Reduced 11.16%
442,579 Common Stock
Jan 31 2025
BUY
Grant, award, or other acquisition
-
194,900 Added 28.12%
498,200 Common Stock
Jan 31 2024
BUY
Grant, award, or other acquisition
-
303,300 Added 50.0%
303,300 Common Stock
NG

Nicholas Grund

Chief Commercial Officer
Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA